TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.24%)
As of: Sep 9, 2026 · 11:58 AM EDT

TAO Synergies (TAOX) Change in Accured Expenses (2019 - 2026)

TAO Synergies' (TAOX) quarterly Change in Accured Expenses came in at -$24972.0 in Q2 2026, up 17.8% on a YoY basis from -$21198.4 in Q2 2025, and up 94.81% quarter-over-quarter from -$481100.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Change in Accured Expenses for 8 consecutive years, with -$24972.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Accured Expenses rose 17.8% year-over-year to -$24972.0; the trailing twelve-month figure through Jun 2026 stood at $66340.0 (up 256.99% YoY), and the FY2025 full-year result was -$58464.0, down 122.39% from the prior year.
  • Change in Accured Expenses rose to -$24972.0 in Q2 2026 per TAOX's latest filing, from -$481100.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $642438.0 in Q4 2024 and bottomed at -$600496.0 in Q1 2025.
  • Historically, Change in Accured Expenses has averaged -$31442.3 across 5 years, with a median of $2030.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 17589.87% in 2024, then jumped 274.48% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $336509.0 in 2022, then gained by 6.79% to $359348.0 in 2023, then jumped by 78.78% to $642438.0 in 2024, then slipped by 14.99% to $546120.0 in 2025, then plunged by 104.57% to -$24972.0 in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$24972.0, -$481100.0, and $546120.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 852.00 Mn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn 338.00 Mn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 222.50 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 492.70 Mn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn -
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn 11.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn 61.62 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn -49.70 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -13.91 Mn
10 TAO Synergies 30.93 Mn 30.93 Mn - -24,972.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24,972.00
Mar 31, 2026 -481,100.00
Dec 31, 2025 546,120.00
Sep 30, 2025 26,292.00
Jun 30, 2025 -30,380.00
Mar 31, 2025 -600,496.00
Dec 31, 2024 642,438.00
Sep 30, 2024 7,021.00
Jun 30, 2024 1,829.00
Mar 31, 2024 -390,199.00
Dec 31, 2023 359,348.00
Sep 30, 2023 8,406.00
Jun 30, 2023 -470,808.00
Mar 31, 2023 2,231.00
Dec 31, 2022 336,509.00
Sep 30, 2022 -144,909.00
Jun 30, 2022 77,125.00
Mar 31, 2022 -430,417.00
Dec 31, 2021 626,450.00
Sep 30, 2021 -49,855.00